Key takeaways for Indiana
- • No GLP-1 is FDA-approved for pre/post-bariatric use specifically.
- • Pre-op: liver shrinkage and risk optimization; post-op: regain management.
- • Observational data show 8-15% additional weight loss post-op on GLP-1.
- • Healthy Indiana Plan / Hoosier Healthwise coverage rules apply for Bariatric Pre- and Post-Op Support patients in Indiana — see Medicaid section below.
- • 13 GLP-1 telehealth providers available nationwide.
Why GLP-1 medications for Bariatric Pre- and Post-Op Support
No GLP-1 is FDA-approved specifically for bariatric pre/post-op support. Off-label preoperative use can reduce liver volume and improve surgical access; off-label postoperative use addresses the roughly 25-30% of bariatric patients who experience clinically significant weight regain. Evidence grade: C (observational data growing; few RCTs). The ASMBS 2022 statement and emerging 2024-2025 consensus recognize this as an evolving practice. Pancreatitis and gastroparesis risks may merit extra caution in altered post-op anatomy.
Indiana-specific context
Indiana has telehealth access concentrated in Indianapolis, Fort Wayne, Evansville metros, with additional reach to South Bend and Carmel. Indiana University Health, Community Health Network is the largest in-state academic medical center for endocrine + obesity-medicine specialty consults. The state health authority publishes prescribing + coverage updates at www.in.gov/health.
Indianatelehealth & pricing rules
- • Indiana permits audio-only and asynchronous telehealth visits for GLP-1 care.
- • Indiana allows new-patient telehealth prescribing without a prior in-person visit.
- • Typical cash GLP-1 price in Indiana: ~$235/mo (compounded options often lower, brand higher).